阴道分娩后难治性产后出血子宫填塞装置有效性系统综述
该系统综述检索至2021年1月,纳入随机和非随机比较研究,评估阴道分娩后宫缩乏力性难治性产后出血使用子宫填塞装置的有效性及纳入机构方案的效果。所有纳入研究偏倚风险高,证据确定性极低至低,各装置对复合结局和子宫切除的影响均不明确。
要点
- 子宫填塞装置对难治性产后出血的效应不明确
- 装置类型和机构方案纳入的作用亦不明确
- 纳入研究偏倚风险高,证据确定性极低至低
核心结论
- 子宫填塞装置治疗阴道分娩后宫缩乏力性难治性产后出血的效果不明确。
- 装置类型和机构方案纳入的作用亦不明确。
研究设计与样本
- 系统综述,检索PubMed、EMBASE、CINAHL、LILACS、POPLINE从建库至2021年1月。
- 纳入随机和非随机比较研究,所有纳入研究偏倚风险高,证据确定性极低至低。
主要发现
- 一项随机研究比较避孕套导管球囊与标准治疗,复合结局RR 2.33(95%CI 0.76-7.14),子宫切除RR 4.14(95%CI 0.48-35.93),结果不明确。
- 一项阶梯楔形整群随机对照试验提示使用避孕套导管或外科手套球囊后复合结局增加(RR 4.08,95%CI 1.07-15.58),子宫切除结果不明确(RR 4.38,95%CI 0.47-41.09)。
- 一项非随机研究显示纳入Bakri球囊后复合结局(RR 0.33,95%CI 0.11-1.03)和子宫切除(RR 0.49,95%CI 0.04-5.38)效应不明确。
- 另一项非随机研究显示纳入Ebb或Bakri球囊后复合结局(RR 0.95,95%CI 0.32-2.81)和子宫切除(RR 1.84,95%CI 0.44-7.69)效应不明确。
临床怎么用
- 现有证据不足以明确推荐子宫填塞装置用于阴道分娩后难治性产后出血。
- 装置类型选择和机构方案纳入需结合临床具体情况谨慎决策。
局限性
- 所有纳入研究偏倚风险高。
- 证据确定性评级为极低至低。
- 比较研究数量有限,部分结局置信区间宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate uterine tamponade devices' effectiveness for atonic refractory postpartum haemorrhage (PPH) after vaginal birth and the effect of including them in institutional protocols. SEARCH STRATEGY: PubMed, EMBASE, CINAHL, LILACS, POPLINE, from inception to January 2021. STUDY SELECTION: Randomised and non-randomised comparative studies. OUTCOMES: Composite outcome including surgical interventions (artery ligations, compressive sutures or hysterectomy) or maternal death, and hysterectomy. RESULTS: All included studies were at high risk of bias. The certainty of the evidence was rated as very low to low. One randomised study measured the effect of the condom-catheter balloon compared with standard care and found unclear results for the composite outcome (relative risk [RR] 2.33, 95% CI 0.76-7.14) and hysterectomy (RR 4.14, 95% CI 0.48-35.93). Three comparative studies assessed the effect of including uterine balloon tamponade in institutional protocols. A stepped wedge cluster randomised controlled trial suggested an increase in the composite outcome (RR 4.08, 95% CI 1.07-15.58) and unclear results for hysterectomy (RR 4.38, 95% CI 0.47-41.09) with the use of the condom-catheter or surgical glove balloon. One non-randomised study showed unclear effects on the composite outcome (RR 0.33, 95% CI 0.11-1.03) and hysterectomy (RR 0.49, 95% CI 0.04-5.38) after the inclusion of the Bakri balloon. The second non-randomised study found unclear effects on the composite outcome (RR 0.95, 95% CI 0.32-2.81) and hysterectomy (RR 1.84, 95% CI 0.44-7.69) after the inclusion of Ebb or Bakri balloon. CONCLUSIONS: The effect of uterine tamponade devices for the management of atonic refractory PPH after vaginal delivery is unclear, as is the role of the type of device and the setting. TWEETABLE ABSTRACT: Unclear effects of uterine tamponade devices and their inclusion in institutional protocols for atonic refractory PPH after vaginal delivery.
引用
- Pingray V, Widmer M, Ciapponi A, et al. Effectiveness of uterine tamponade devices for refractory postpartum haemorrhage after vaginal birth: a systematic review. BJOG. 2021. PMID: 34165867. doi:10.1111/1471-0528.16819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。